• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    UFP Technologies Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    6/6/25 10:45:00 AM ET
    $UFPT
    Medical/Dental Instruments
    Health Care
    Get the next $UFPT alert in real time by email
    false 0000914156 0000914156 2025-06-04 2025-06-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    _____________________

     

    FORM 8-K
    _____________________

     

    Current Report Pursuant to
    Section 13 or 15(d) of the
    Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event Reported): June 4, 2025  

     

    UFP Technologies, Inc.
    (Exact Name of Registrant as Specified in Charter)
     
    Delaware
    (State or Other Jurisdiction of Incorporation)

     

    001-12648   04-2314970
    (Commission File Number)   (I.R.S. Employer Identification Number)
         
    100 Hale Street, Newburyport, MA - USA   01950-3504
    (Address of Principal Executive Offices)   (Zip Code)

     

    978-352-2200
    (Registrant's telephone number, including area code)
     
    N/A
    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
      ☐   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
      ☐   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
      ☐   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
      ☐   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class Trading Symbol(s) Name of each exchange on which registered
    Common Stock UFPT The NASDAQ Stock Market L.L.C.

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

    Item 5.07      Submission of Matters to a Vote of Security Holders.

     

    On June 4, 2025, the Company held its Annual Meeting of Stockholders. The final results for each of the matters submitted to a vote of stockholders at the meeting are set forth below. A more detailed description of each proposal is set forth in the Company’s definitive proxy statement on Form DEF 14A, filed with the U.S. Securities and Exchange Commission on April 30, 2025 (the “Proxy Statement”).

     

    Proposal No. 1. Election of Directors. The stockholders elected seven (7) nominees for director to serve until the Company’s 2026 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, by the votes set forth in the table below:

     

    Name   For   Withheld     Broker Non-Vote
    R. Jeffrey Bailly   6,159,251   336,539     419,029
    Thomas Oberdorf   6,111,110   384,680     419,029
    Marc Kozin   6,129,214   366,576     419,029
    Daniel C. Croteau   6,255,535   240,255     419,029
    Cynthia L. Feldmann   6,293,368   202,422     419,029
    Joseph John Hassett   6,289,678   206,112     419,029
    Symeria Hudson   6,311,434   184,356     419,029

     

    Proposal No. 2. Advisory Vote on Executive Compensation. The stockholders approved, a non-binding advisory, resolution to approve executive compensation, as described in the Proxy Statement, by the votes set forth in the table below:

     

    For   Against   Abstained   Broker Non-Vote
    5,684,666   799,852   11,272   419,029

     

     

    Proposal No. 3. Advisory Vote on the Frequency of Named Executive Officer Compensation. The stockholders approved, on an advisory basis, the frequency of future advisory votes on the compensation of the Company’s named executive officers. The result of the vote taken at the 2025 Annual Meeting was as follows:

     

    1 Year   2 Years   3 Years   Abstained
    5,996,792   20,166   458,510   20,322

     

     

    Proposal No. 4. Ratification of Appointment of Independent Registered Public Accounting Firm. The stockholders ratified the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025, by the votes set forth in the table below:

     

    For   Against   Abstained   Broker Non-Vote
    6,445,924   467,520   1,375   N/A

     

     

     

     

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

     

    Dated: June 6, 2025 UFP TECHNOLOGIES, INC.  
           
           
           
      By: /s/ Ronald J. Lataille  
       

    Ronald J. Lataille

    Chief Financial Officer and Senior Vice President

         

     

     

     

     

     

     

     

    Get the next $UFPT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $UFPT

    DatePrice TargetRatingAnalyst
    3/28/2025Mkt Perform
    Raymond James
    7/17/2024$344.00 → $392.00Buy
    Lake Street
    3/20/2024Market Outperform
    CJS Securities
    2/6/2024Sector Weight
    KeyBanc Capital Markets
    12/21/2022$124.00Buy
    Lake Street
    6/22/2022$110.00Buy
    Lake Street
    11/19/2021$81.00Buy
    Colliers Securities
    More analyst ratings

    $UFPT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • UFP Technologies to Present and Host 1x1 Investor Meetings at the 15th Annual East Coast IDEAS Investor Conference on June 11th in New York, NY

      NEWBURYPORT, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- UFP Technologies (UFPT), today announced Jeffrey Bailly, Chairman and CEO and Ron Lataille, Sr. Vice President & CFO, will present at the East Coast IDEAS Investor Conference on Wednesday, June 11, 2025 at The Westin Times Square in New York, NY. UFP's presentation is scheduled to begin at 7:55 AM ET. The presentation is webcast and can be accessed through the conference host's main website: https://www.threepartadvisors.com/east-coast and in the investor relations section of the company's website: http://www.UFPT.com. About IDEAS Investor Conferences The mission of the IDEAS Conferences is to provide independent regional venues f

      6/3/25 9:00:53 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the Goldman Sachs 46th Annual Global Healthcare Conference

      NEWBURYPORT, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), today announced that Jeffrey Bailly, Chairman and CEO, and Ron Lataille, Sr. Vice President & CFO, will present at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025. UFP's fireside chat is scheduled to begin at 11:20 AM ET. About UFP Technologies, Inc. UFP Technologies is a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. UFP is an important link in the medical device supply chain and a valued outsourcing partner to many of the top medical device manufacturers in the wor

      6/3/25 9:00:26 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • UFP Technologies Announces Record Q1 Results

      NEWBURYPORT, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions primarily for the medical market, today reported net income of $17.2 million or $2.21 per diluted common share outstanding for its first quarter ended March 31, 2025, compared to net income of $12.7 million or $1.64 per diluted common share outstanding for the first quarter of 2024. Net Sales for the first quarter were $148.1 million compared to 2024 first quarter sales of $105.0 million. Throughout this news release, reference is made to non-GAAP measures including organic sales growth, adjusted operating income, adjusted SG&A, adjusted n

      5/6/25 9:00:56 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care

    $UFPT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Raymond James initiated coverage on UFP Technologies

      Raymond James initiated coverage of UFP Technologies with a rating of Mkt Perform

      3/28/25 8:21:18 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • Lake Street reiterated coverage on UFP Technologies with a new price target

      Lake Street reiterated coverage of UFP Technologies with a rating of Buy and set a new price target of $392.00 from $344.00 previously

      7/17/24 8:57:19 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • CJS Securities initiated coverage on UFP Technologies

      CJS Securities initiated coverage of UFP Technologies with a rating of Market Outperform

      3/20/24 9:43:53 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care

    $UFPT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by UFP Technologies Inc.

      SC 13G - UFP TECHNOLOGIES INC (0000914156) (Subject)

      11/13/24 9:58:23 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by UFP Technologies Inc. (Amendment)

      SC 13G/A - UFP TECHNOLOGIES INC (0000914156) (Subject)

      3/8/24 3:02:25 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by UFP Technologies Inc.

      SC 13G - UFP TECHNOLOGIES INC (0000914156) (Subject)

      2/13/24 5:16:09 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care

    $UFPT
    SEC Filings

    See more
    • UFP Technologies Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - UFP TECHNOLOGIES INC (0000914156) (Filer)

      6/6/25 10:45:00 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • SEC Form 10-Q filed by UFP Technologies Inc.

      10-Q - UFP TECHNOLOGIES INC (0000914156) (Filer)

      5/12/25 8:31:10 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • SEC Form 144 filed by UFP Technologies Inc.

      144 - UFP TECHNOLOGIES INC (0000914156) (Subject)

      5/8/25 3:49:36 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care

    $UFPT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Hassett Joseph was granted 625 shares, increasing direct ownership by 53% to 1,800 units (SEC Form 4)

      4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

      6/6/25 2:52:16 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • Director Hudson Symeria was granted 625 shares, increasing direct ownership by 118% to 1,153 units (SEC Form 4)

      4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

      6/6/25 2:50:51 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • Director Feldmann Cynthia L was granted 625 shares, increasing direct ownership by 15% to 4,674 units (SEC Form 4)

      4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

      6/6/25 2:50:08 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care

    $UFPT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Lataille Ronald J bought $91,636 worth of shares (400 units at $229.09), increasing direct ownership by 3% to 15,031 units (SEC Form 4)

      4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

      2/27/25 3:57:17 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Lataille Ronald J

      4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

      11/13/23 11:09:49 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • Rock Mitchell bought $27,522 worth of shares (198 units at $139.00), increasing direct ownership by 0.74% to 27,086 units (SEC Form 4)

      4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

      11/9/23 5:21:17 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care

    $UFPT
    Leadership Updates

    Live Leadership Updates

    See more
    • UFP Technologies Acquires AQF Medical

      NEWBURYPORT, Mass., Aug. 26, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of AQF Limited ("AQF Medical"). Headquartered in Navan, Ireland with additional joint venture operations in Singapore, AQF Medical develops and manufactures custom-engineered foam and thermoplastic components used in a wide range of medical devices and packaging. "We are excited about the addition of AQF Medical, our fourth acquisition in the past few months," said R. Jeffrey Bailly, Chairman and CEO of UFP Technologies.

      8/26/24 9:00:00 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • UFP Technologies Acquires Marble Medical

      NEWBURYPORT, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of Marble Medical. Founded in 1988 and headquartered in Tallahassee, FL, Marble Medical develops and manufactures adhesive based medical components and single-use devices. "Adding Marble Medical's adhesives expertise is a great complement to our surgical robot drapes and stick to skin device platforms," said R. Jeffrey Bailly, chairman and CEO of UFP Technologies. "Marble Medical is a 3M Preferred Converter, and along wi

      7/16/24 4:05:00 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • Chimerix Appoints Marc D. Kozin to Board of Directors

      DURHAM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced the appointment of Marc D. Kozin as the newest member of the Company's Board of Directors. In addition, Patrick Machado has announced his retirement from the Chimerix Board effective at the Company's 2024 Annual Meeting of Stockholders in June, after ten years of service. "We are pleased to welcome Marc to the Board of Directors. Marc's strategic insights and leadership will undoubtedly contribute to the continued growth and success of Chimerix as we wo

      3/21/24 7:00:00 AM ET
      $CMRX
      $UFPT
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Medical/Dental Instruments

    $UFPT
    Financials

    Live finance-specific insights

    See more
    • UFP Technologies Announces Record Q1 Results

      NEWBURYPORT, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions primarily for the medical market, today reported net income of $17.2 million or $2.21 per diluted common share outstanding for its first quarter ended March 31, 2025, compared to net income of $12.7 million or $1.64 per diluted common share outstanding for the first quarter of 2024. Net Sales for the first quarter were $148.1 million compared to 2024 first quarter sales of $105.0 million. Throughout this news release, reference is made to non-GAAP measures including organic sales growth, adjusted operating income, adjusted SG&A, adjusted n

      5/6/25 9:00:56 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • UFP Technologies to Report First Quarter 2025 Financial Results on May 6, 2025

      NEWBURYPORT, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of components for medical devices, sterile packaging, and other highly engineered products, today announced the Company plans to report financial results for the first quarter ended March 31, 2025 on May 6, 2025 prior to market open. The Company will hold a conference call to discuss results the same day at 10:00 AM Eastern time. Conference Call Information:Date: Tuesday, May 6, 2025Time: 10:00 AM Eastern TimeParticipants may join the call using the following dial-in numbers: Toll-Free: 1-888-243-4451International: 1-412-542-4135 A live webcast of t

      4/30/25 9:00:43 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • UFP Technologies to Report Fourth Quarter and Year-end 2024 Results on February 25, 2025

      NEWBURYPORT, Mass., Feb. 19, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today announced that the Company plans to report results for the fourth quarter and year-ended December 31, 2024, on Tuesday, February 25th. About UFP Technologies, Inc. UFP Technologies is an innovative designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. UFP is an important link in the medical device supply chain and a valued outsource partner to man

      2/19/25 9:00:38 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care